EP
KRRO icon

Essential Partners’s Korro Bio KRRO Stock Holding History

Essential Partners’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37K Sell
180
-1,142
-86% -$14.2K ﹤0.01% 1907
2026
Q1 		$15K Buy
+1,322
New +$14.6K 0.01% 1048
2025
Q4 		– Sell
-394
Closed -$18.9K – 2849
2025
Q3 		$18.9K Buy
394
+391
+13,033% +$8.68K 0.01% 912
2025
Q2 		$37 Buy
+3
New +$43 ﹤0.01% 2176

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Essential Partners's KRRO Position: Q2 2026 in Review

Essential Partners reduced its Korro Bio (KRRO) stake by 86% in Q2 2026, selling an estimated $14.2K and leaving 180 shares worth $2.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Essential Partners first reported a position in KRRO in Q2 2025 and has held it in 4 quarters since. The position peaked at $18.9K in Q3 2025. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Essential Partners held 180 shares of Korro Bio worth $2.37K as of Q2 2026.
  • Essential Partners sold 1,142 Korro Bio shares in Q2 2026, an estimated $14.2K.
  • Korro Bio made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1907 holding.
  • Essential Partners first reported a position in Korro Bio in Q2 2025 and has held it in 4 quarters since.
  • Essential Partners's Korro Bio position peaked at $18.9K in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.